Tag: Justin Ishbia
Home infusion market sees supply-and-demand issues
September 14, 2018Theresa Flaherty, Managing Editor
YARMOUTH, Maine - It has been a hot market in the past, but there aren't a lot of deals being done in home infusion these days, mainly due to a shortage of inventory, say M&A analysts.“There are fewer new startups and the other guys have been consolidating,” said Reg Blackburn, managing director of specialty pharmacy and infusion services for The Braff Group. “It's definitely a supply and demand issue.”That's good news for sellers, with valuations in home infusion remaining...
Home infusion market refuses to stand still
April 8, 2016Theresa Flaherty, Managing Editor
YARMOUTH, Maine - When it comes to mergers and acquisitions in the home infusion space, analysts report seeing a “blurring of the lines” among its different segments.“Just like our HME channels are blurring lines between providers and insurers, the same thing is happening with home infusion,” said Jonathan Sadock, managing partner with Paragon Ventures. “It's becoming where it is not unusual to find an infusion provider and a specialty pharmacy all rolled together.”Other...
'Changing landscape'
December 22, 2015Theresa Flaherty, Managing Editor
EDEN PRAIRIE, Minn. - OptumRx's recent purchase of AxelaCare Health Solutions, a home infusion services provider, points to a larger trend of both pharmacy benefit managers and payers bringing other services under their umbrellas, analysts say.
“This is the changing landscape in health care,” said Justin Ishbia, founder and managing partner of Shore Capital Partners, a private equity firm that used to own SCP Specialty Infusion. “They are the payer but they are also the provider...
Walgreens keeps hand in home infusion
January 30, 2015Theresa Flaherty, Managing Editor
DEERFIELD, Ill. - The sale of its home infusion business to a private equity firm will give Walgreens the chance to double down on the growing market.“Walgreens believes in the home infusion industry,” said Justin Ishbia, founder and managing partner of Shore Capital Partners, a private equity firm that used own a competing home infusion company. “They're not trying to exit it.”Per the deal, announced Jan. 20, Madison Dearborn Partners, a Chicago-based private equity firm,...